郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Characterization of the cellular activity of PDE 4 inhibitors using two novel PDE 4 reporter cell lines.

期刊：Molecular pharmaceutics发表年份：2013作者：Frank Wunder; Ramona Quednau; Andreas Geerts; Martina Barg; Adrian Tersteegen
阅读更多 →

药效评价Agonist pharmacology at recombinant α1A - and α1L -adrenoceptors and in lower urinary tract α1 -adrenoceptors.

期刊：British journal of pharmacology发表年份：2013作者：Hatsumi Yoshiki; Junsuke Uwada; Hidenori Umada; Tadashi Kobayashi; Toshihiro Takahashi; Tomio Yamakawa; Akio Yamaguchi; Osamu Yokoyama; Ikunobu Muramatsu
阅读更多 →

药效评价Investigating monoclonal antibody aggregation using a combination of H/DX-MS and other biophysical measurements.

期刊：Journal of pharmaceutical sciences发表年份：2013作者：Roxana E Iacob; George M Bou-Assaf; Lee Makowski; John R Engen; Steven A Berkowitz; Damian Houde
阅读更多 →

药效评价Efficient expression and purification of recombinant therapeutic protein candidates, human midkine and pleiotrophin.

期刊：Current pharmaceutical biotechnology发表年份：2013作者：Akira Murasugi
阅读更多 →